NEW TAIPEI CITY, May 11, 2024 /PRNewswire/ — Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the…
Read More »advancements
© Reuters. Tuesday, Silence Therapeutics (NASDAQ:SLN) maintained its Outperform rating and $67.00 price target from BMO Capital. The firm’s continued…
Read More »